SEC Form 4 · accession 0001055726-18-000023
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B. Weiner
Director
Period of report
Apr 16, 2018
Accepted (ET)
Apr 19, 2018 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 16, 2018 | S | 9,000 | $4.9114 | D | 758,956 | D |
Table II — derivative securities
No Table II lines on this filing.